-
1
-
-
0344313863
-
Medullary carcinoma of thyroid
-
Braverman L.E., and Utiger R.D. (Eds), JB Lippincott Company, New York
-
Bustros A.C., and Baylin S.B. Medullary carcinoma of thyroid. In: Braverman L.E., and Utiger R.D. (Eds). Werner and Ingbar's the thyroid (1991), JB Lippincott Company, New York 1167
-
(1991)
Werner and Ingbar's the thyroid
, pp. 1167
-
-
Bustros, A.C.1
Baylin, S.B.2
-
2
-
-
14444272505
-
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Group d'etude des tumeurs a calcitonine
-
Modigliani E., Cohen R., Campos J.M., et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Group d'etude des tumeurs a calcitonine. Clin Endocrin (Oxf) 48 (1998) 265-273
-
(1998)
Clin Endocrin (Oxf)
, vol.48
, pp. 265-273
-
-
Modigliani, E.1
Cohen, R.2
Campos, J.M.3
-
3
-
-
0028816916
-
Endocrine gland cancer
-
Correa P., and Chen V.W. Endocrine gland cancer. Cancer 75 (1995) 338-352
-
(1995)
Cancer
, vol.75
, pp. 338-352
-
-
Correa, P.1
Chen, V.W.2
-
4
-
-
0028819736
-
Medullary thyroid carcinoma: recent advances and management update
-
Marsh D.J., Learoyd D.L., and Robinson B.G. Medullary thyroid carcinoma: recent advances and management update. Thyroid 5 (1995) 407-424
-
(1995)
Thyroid
, vol.5
, pp. 407-424
-
-
Marsh, D.J.1
Learoyd, D.L.2
Robinson, B.G.3
-
5
-
-
0028114304
-
Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B
-
O'Riordain D.S., O'Brien T., Weaver A.L., et al. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery 116 (1994) 1017-1023
-
(1994)
Surgery
, vol.116
, pp. 1017-1023
-
-
O'Riordain, D.S.1
O'Brien, T.2
Weaver, A.L.3
-
6
-
-
0021746211
-
Medullary carcinoma of the thyroid: a study of the clinical and prognostic factors in 161 patients
-
Saad M.F., Ordonez N.G., Rashid R.K., et al. Medullary carcinoma of the thyroid: a study of the clinical and prognostic factors in 161 patients. Medicine 63 (1984) 319-342
-
(1984)
Medicine
, vol.63
, pp. 319-342
-
-
Saad, M.F.1
Ordonez, N.G.2
Rashid, R.K.3
-
7
-
-
0025761506
-
Medullary carcinoma of the thyroid: current diagnosis and management
-
Lairmore T.C., and Wells Jr. S.A. Medullary carcinoma of the thyroid: current diagnosis and management. Semin Surg Oncol 7 (1991) 92-99
-
(1991)
Semin Surg Oncol
, vol.7
, pp. 92-99
-
-
Lairmore, T.C.1
Wells Jr., S.A.2
-
8
-
-
0025102876
-
Changing concepts in the management of hereditary and sporadic medullary carcinoma
-
Grauer A., Raue F., and Gagel R. Changing concepts in the management of hereditary and sporadic medullary carcinoma. Endocrinol Metab Clin North Am 19 (1990) 613-635
-
(1990)
Endocrinol Metab Clin North Am
, vol.19
, pp. 613-635
-
-
Grauer, A.1
Raue, F.2
Gagel, R.3
-
9
-
-
0028217843
-
Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma
-
Abdelmoumene N., Schlumberger M., Gardet P., et al. Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Br J Cancer 69 (1994) 1141-1144
-
(1994)
Br J Cancer
, vol.69
, pp. 1141-1144
-
-
Abdelmoumene, N.1
Schlumberger, M.2
Gardet, P.3
-
10
-
-
0024438497
-
Diagnostic procedure before reoperation in patients with medullary thyroid carcinoma
-
Raue F., Winter J., Frank-Raue K., et al. Diagnostic procedure before reoperation in patients with medullary thyroid carcinoma. Horm Metab Res Suppl 21 (1989) 31-34
-
(1989)
Horm Metab Res Suppl
, vol.21
, pp. 31-34
-
-
Raue, F.1
Winter, J.2
Frank-Raue, K.3
-
11
-
-
0026751978
-
Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization
-
Frank-Raue K., Raue F., Buhr H.J., et al. Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid 2 (1992) 113-117
-
(1992)
Thyroid
, vol.2
, pp. 113-117
-
-
Frank-Raue, K.1
Raue, F.2
Buhr, H.J.3
-
12
-
-
0018862250
-
Localization and resection of clinically inapparent medullary carcinoma of the thyroid
-
Norton J.A., Doppman J.L., and Brennan M.F. Localization and resection of clinically inapparent medullary carcinoma of the thyroid. Surgery 87 (1980) 616-622
-
(1980)
Surgery
, vol.87
, pp. 616-622
-
-
Norton, J.A.1
Doppman, J.L.2
Brennan, M.F.3
-
13
-
-
0023099793
-
Sonography in the follow-up of 100 patients with thyroid carcinoma
-
Simeone J.F., Daniels G.H., Hall D.A., et al. Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR Am J Roentgenol 148 (1987) 45-49
-
(1987)
AJR Am J Roentgenol
, vol.148
, pp. 45-49
-
-
Simeone, J.F.1
Daniels, G.H.2
Hall, D.A.3
-
14
-
-
0023683665
-
Recurrent thyroid carcinoma: characteristics on MR images
-
Auffermann W., Clark O.H., Thurnber S., et al. Recurrent thyroid carcinoma: characteristics on MR images. Radiology 168 (1988) 753-757
-
(1988)
Radiology
, vol.168
, pp. 753-757
-
-
Auffermann, W.1
Clark, O.H.2
Thurnber, S.3
-
15
-
-
0024339172
-
Recurrent occult medullary thyroid carcinoma detected by MR imaging
-
Crow J.P., Azar-Kia B., and Prinz R.A. Recurrent occult medullary thyroid carcinoma detected by MR imaging. AJR Am J Roentgenol 152 (1989) 1255-1256
-
(1989)
AJR Am J Roentgenol
, vol.152
, pp. 1255-1256
-
-
Crow, J.P.1
Azar-Kia, B.2
Prinz, R.A.3
-
16
-
-
0032808637
-
Detection of medullary thyroid carcinoma and regional lymph node metastases by magnetic resonance imaging
-
Wang Q., Takashima S., Fukuda H., et al. Detection of medullary thyroid carcinoma and regional lymph node metastases by magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 125 (1999) 842-848
-
(1999)
Arch Otolaryngol Head Neck Surg
, vol.125
, pp. 842-848
-
-
Wang, Q.1
Takashima, S.2
Fukuda, H.3
-
18
-
-
0027336779
-
Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative study
-
Dörr U., Würstlin S., Frank-Raue K., et al. Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative study. Horm Metab Res Suppl 27 (1993) 48-55
-
(1993)
Horm Metab Res Suppl
, vol.27
, pp. 48-55
-
-
Dörr, U.1
Würstlin, S.2
Frank-Raue, K.3
-
19
-
-
0030162739
-
Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma
-
Baudin E., Lumbroso J., Schlumberger M., et al. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. J Nucl Med 37 (1996) 912-916
-
(1996)
J Nucl Med
, vol.37
, pp. 912-916
-
-
Baudin, E.1
Lumbroso, J.2
Schlumberger, M.3
-
20
-
-
0034945777
-
Imaging tumors with peptide-based radioligands
-
Behr T.M., Gotthardt M., Barth A., et al. Imaging tumors with peptide-based radioligands. Q J Nucl Med 45 (2001) 189-200
-
(2001)
Q J Nucl Med
, vol.45
, pp. 189-200
-
-
Behr, T.M.1
Gotthardt, M.2
Barth, A.3
-
21
-
-
0032921175
-
Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid
-
Krausz Y., Rosler A., Guttmann H., et al. Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid. Clin Nucl Med 24 (1999) 256-260
-
(1999)
Clin Nucl Med
, vol.24
, pp. 256-260
-
-
Krausz, Y.1
Rosler, A.2
Guttmann, H.3
-
22
-
-
15644376162
-
Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma
-
Berna L., Chico A., Matias-Guiu X., et al. Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma. Eur J Nucl Med 25 (1998) 1482-1488
-
(1998)
Eur J Nucl Med
, vol.25
, pp. 1482-1488
-
-
Berna, L.1
Chico, A.2
Matias-Guiu, X.3
-
23
-
-
0034919634
-
Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery
-
Arslan N., Ilgan S., Yuksel D., et al. Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery. Clin Nucl Med 26 (2001) 683-688
-
(2001)
Clin Nucl Med
, vol.26
, pp. 683-688
-
-
Arslan, N.1
Ilgan, S.2
Yuksel, D.3
-
24
-
-
0028985505
-
111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma
-
Berna L., Cabezas R., Mora J., et al. 111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma. J Endocrinol 144 (1995) 339-345
-
(1995)
J Endocrinol
, vol.144
, pp. 339-345
-
-
Berna, L.1
Cabezas, R.2
Mora, J.3
-
25
-
-
0030901828
-
Comparison of In-111 pentetreotide, Tc-99m (V)-DMSA and I-123 MlBG scintimaging in neural crest tumors
-
Limouris G.S., Giannakopoulos V., Stavraka A., et al. Comparison of In-111 pentetreotide, Tc-99m (V)-DMSA and I-123 MlBG scintimaging in neural crest tumors. Anticancer Res 17 (1997) 1589-1592
-
(1997)
Anticancer Res
, vol.17
, pp. 1589-1592
-
-
Limouris, G.S.1
Giannakopoulos, V.2
Stavraka, A.3
-
26
-
-
0028143013
-
Detection of medullary carcinoma of the thyroid with I-131 MIBG
-
Thomas C.C., Cowan R.J., Albertson D.A., et al. Detection of medullary carcinoma of the thyroid with I-131 MIBG. Clin Nucl Med 19 (1994) 1066-1068
-
(1994)
Clin Nucl Med
, vol.19
, pp. 1066-1068
-
-
Thomas, C.C.1
Cowan, R.J.2
Albertson, D.A.3
-
27
-
-
0025042982
-
The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG): 5 years of experience
-
Troncone L., Rufini V., Montemaggi P., et al. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG): 5 years of experience. Eur J Nucl Med 16 (1990) 325-335
-
(1990)
Eur J Nucl Med
, vol.16
, pp. 325-335
-
-
Troncone, L.1
Rufini, V.2
Montemaggi, P.3
-
28
-
-
0031047093
-
Technetium-99-sestamibi scanning in recurrent medullary thyroid carcinoma
-
Learoyd D.L., Roach P.J., Briggs G.M., et al. Technetium-99-sestamibi scanning in recurrent medullary thyroid carcinoma. J Nucl Med 38 (1997) 227-230
-
(1997)
J Nucl Med
, vol.38
, pp. 227-230
-
-
Learoyd, D.L.1
Roach, P.J.2
Briggs, G.M.3
-
29
-
-
0029665302
-
99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid
-
99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Eur J Nucl Med 23 (1996) 1367-1371
-
(1996)
Eur J Nucl Med
, vol.23
, pp. 1367-1371
-
-
Ugur, O.1
Kostakoglu, L.2
Güler, N.3
-
30
-
-
0023882933
-
New radionuclide tracers for the diagnosis and therapy of the medullary thyroid carcinoma
-
Hoefnagel C.A., Delprat C.C., Zanin D., et al. New radionuclide tracers for the diagnosis and therapy of the medullary thyroid carcinoma. Clin Nucl Med 13 (1988) 159-165
-
(1988)
Clin Nucl Med
, vol.13
, pp. 159-165
-
-
Hoefnagel, C.A.1
Delprat, C.C.2
Zanin, D.3
-
31
-
-
0024417593
-
Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma
-
Manil L., Boudet F., Motte P., et al. Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma. Cancer Res 49 (1989) 5480-5485
-
(1989)
Cancer Res
, vol.49
, pp. 5480-5485
-
-
Manil, L.1
Boudet, F.2
Motte, P.3
-
32
-
-
0022952390
-
Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment
-
Reiners C., Eilles C., Spiegel W., et al. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment. Nuklearmedizin 25 (1986) 227-231
-
(1986)
Nuklearmedizin
, vol.25
, pp. 227-231
-
-
Reiners, C.1
Eilles, C.2
Spiegel, W.3
-
33
-
-
0027166186
-
Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer
-
Peltier P., Curtet C., Chatal J.-F., et al. Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med 34 (1993) 1267-1273
-
(1993)
J Nucl Med
, vol.34
, pp. 1267-1273
-
-
Peltier, P.1
Curtet, C.2
Chatal, J.-F.3
-
34
-
-
0031945355
-
Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnosis and therapeutic potential of radiolabelled gastrin
-
Behr T.M., Jenner N., Radetzky S., et al. Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnosis and therapeutic potential of radiolabelled gastrin. Eur J Nucl Med 25 (1998) 424-430
-
(1998)
Eur J Nucl Med
, vol.25
, pp. 424-430
-
-
Behr, T.M.1
Jenner, N.2
Radetzky, S.3
-
35
-
-
0033001991
-
Radiolabelled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors
-
Behr T.M., Jenner J., Behe M., et al. Radiolabelled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors. J Nucl Med 40 (1999) 1029-1040
-
(1999)
J Nucl Med
, vol.40
, pp. 1029-1040
-
-
Behr, T.M.1
Jenner, J.2
Behe, M.3
-
36
-
-
0025845450
-
The application of PET in clinical oncology
-
Strauss L.G., and Conti P.S. The application of PET in clinical oncology. J Nucl Med 32 (1991) 623-648
-
(1991)
J Nucl Med
, vol.32
, pp. 623-648
-
-
Strauss, L.G.1
Conti, P.S.2
-
37
-
-
0031440206
-
Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma
-
Gasparoni P., Rubello D., and Ferlin G. Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma. J Endocrinol Invest 20 (1997) 527-530
-
(1997)
J Endocrinol Invest
, vol.20
, pp. 527-530
-
-
Gasparoni, P.1
Rubello, D.2
Ferlin, G.3
-
38
-
-
0034756055
-
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: result of a multicenter study
-
Diehl M., Risse J.H., Brandt-Mainz K., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: result of a multicenter study. Eur J Nucl Med 28 (2001) 1671-1676
-
(2001)
Eur J Nucl Med
, vol.28
, pp. 1671-1676
-
-
Diehl, M.1
Risse, J.H.2
Brandt-Mainz, K.3
-
39
-
-
0033457279
-
Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicenter study
-
Grünwald F., Kälicke T., Feine U., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicenter study. Eur J Nucl Med 26 (1999) 1547-1552
-
(1999)
Eur J Nucl Med
, vol.26
, pp. 1547-1552
-
-
Grünwald, F.1
Kälicke, T.2
Feine, U.3
-
40
-
-
0034173478
-
Role of nuclear medicine in the diagnosis and therapy of medullary thyroid carcinoma
-
Rufini V., Salvatori M., Garganese M.C., et al. Role of nuclear medicine in the diagnosis and therapy of medullary thyroid carcinoma. Rays 25 (2000) 273-282
-
(2000)
Rays
, vol.25
, pp. 273-282
-
-
Rufini, V.1
Salvatori, M.2
Garganese, M.C.3
-
41
-
-
6944231270
-
Impact of F-18 fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer
-
de Groot J.W., Links T.P., Jager P.L., et al. Impact of F-18 fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 11 8 (2004) 786-794
-
(2004)
Ann Surg Oncol
, vol.11
, Issue.8
, pp. 786-794
-
-
de Groot, J.W.1
Links, T.P.2
Jager, P.L.3
-
42
-
-
0034020925
-
The value of F-18 FDG PET in patients with medullary thyroid cancer
-
Brandt-Mainz K., Muller S.P., Gorges R., et al. The value of F-18 FDG PET in patients with medullary thyroid cancer. Eur J Nucl Med 27 (2000) 490-496
-
(2000)
Eur J Nucl Med
, vol.27
, pp. 490-496
-
-
Brandt-Mainz, K.1
Muller, S.P.2
Gorges, R.3
-
43
-
-
0036007410
-
F-18 FDG-PET detection of lymph node metastases in medullary thyroid carcinoma
-
Szakall Jr. S., Esik O., Balzik G., et al. F-18 FDG-PET detection of lymph node metastases in medullary thyroid carcinoma. J Nucl Med 43 1 (2002) 66-71
-
(2002)
J Nucl Med
, vol.43
, Issue.1
, pp. 66-71
-
-
Szakall Jr., S.1
Esik, O.2
Balzik, G.3
-
44
-
-
0347824357
-
FDG-PET in thyroid cancer
-
Crippa F., Alessi A., Gerali A., et al. FDG-PET in thyroid cancer. Tumori 89 (2003) 540-543
-
(2003)
Tumori
, vol.89
, pp. 540-543
-
-
Crippa, F.1
Alessi, A.2
Gerali, A.3
-
45
-
-
0030201169
-
PET and [18F]-FDG in oncology: a clinical update
-
Conti P.S., Lilien D.L., Hawley K., et al. PET and [18F]-FDG in oncology: a clinical update. Nucl Med Biol 23 (1996) 717-735
-
(1996)
Nucl Med Biol
, vol.23
, pp. 717-735
-
-
Conti, P.S.1
Lilien, D.L.2
Hawley, K.3
-
46
-
-
0037277902
-
Diagnosis in medullary thyroid cancer with F-18 FDG-PET and improvent using a combined PET/CT scanner
-
Bockish A., Brandt-Mainz K., Görges R., et al. Diagnosis in medullary thyroid cancer with F-18 FDG-PET and improvent using a combined PET/CT scanner. Acta Med Austriaca 30 (2003) 22-25
-
(2003)
Acta Med Austriaca
, vol.30
, pp. 22-25
-
-
Bockish, A.1
Brandt-Mainz, K.2
Görges, R.3
-
47
-
-
33847411464
-
Detection of occult medullary thyroid cancer recurrence with 2-Deoxy-2-[F-18]fluoro-d-glucose-PET and PET/CT
-
Iagaru A., Masamed R., Singer P.A., et al. Detection of occult medullary thyroid cancer recurrence with 2-Deoxy-2-[F-18]fluoro-d-glucose-PET and PET/CT. Mol Imaging Biol 9 (2007) 72-77
-
(2007)
Mol Imaging Biol
, vol.9
, pp. 72-77
-
-
Iagaru, A.1
Masamed, R.2
Singer, P.A.3
-
48
-
-
0031910371
-
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography fort the imaging neuroendocrine tumors
-
Adams S., Baum R., Rink T., et al. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography fort the imaging neuroendocrine tumors. Eur J Nucl Med 25 (1998) 79-83
-
(1998)
Eur J Nucl Med
, vol.25
, pp. 79-83
-
-
Adams, S.1
Baum, R.2
Rink, T.3
-
49
-
-
0028033611
-
FDG-PET for predicting the prognosis of malignant lymphoma
-
Okada J., Oonishi H., Yoshikawa K., et al. FDG-PET for predicting the prognosis of malignant lymphoma. Ann Nucl Med 8 (1994) 187-191
-
(1994)
Ann Nucl Med
, vol.8
, pp. 187-191
-
-
Okada, J.1
Oonishi, H.2
Yoshikawa, K.3
-
50
-
-
0029779869
-
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer
-
Feine U., Lietzenmayer R., Hanke J.P., et al. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37 (1996) 1468-1472
-
(1996)
J Nucl Med
, vol.37
, pp. 1468-1472
-
-
Feine, U.1
Lietzenmayer, R.2
Hanke, J.P.3
-
51
-
-
0031443576
-
Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study
-
[discussion: 1060-1]
-
Musholt T.J., Musholt P.B., Dehdashti F., et al. Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study. Surgery 122 (1997) 1049-1060 [discussion: 1060-1]
-
(1997)
Surgery
, vol.122
, pp. 1049-1060
-
-
Musholt, T.J.1
Musholt, P.B.2
Dehdashti, F.3
-
52
-
-
0032871248
-
Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography
-
Conti P.S., Durski J.M., Bacqai F., et al. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 9 (1999) 797-804
-
(1999)
Thyroid
, vol.9
, pp. 797-804
-
-
Conti, P.S.1
Durski, J.M.2
Bacqai, F.3
-
53
-
-
0029971787
-
In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine
-
Bergström M., Erikson B., Öberg K., et al. In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine. J Nucl Med 37 (1996) 32-37
-
(1996)
J Nucl Med
, vol.37
, pp. 32-37
-
-
Bergström, M.1
Erikson, B.2
Öberg, K.3
-
54
-
-
0014510423
-
The cytochemistry and ultrastructure of polypeptide hormone producing cells of APUD series and the embryologic, physiologic and pathologic implications of the concept
-
Pearse A.G. The cytochemistry and ultrastructure of polypeptide hormone producing cells of APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 17 (1969) 303-308
-
(1969)
J Histochem Cytochem
, vol.17
, pp. 303-308
-
-
Pearse, A.G.1
-
55
-
-
0035095729
-
Radiolabelled amino acids: basic aspects and clinical applications in oncology
-
Jager P.L., Vaalburg W., Pruim J., et al. Radiolabelled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42 (2001) 432-435
-
(2001)
J Nucl Med
, vol.42
, pp. 432-435
-
-
Jager, P.L.1
Vaalburg, W.2
Pruim, J.3
-
56
-
-
0028962933
-
Pancreatic neuroendocrine tumors: diagnosis with PET
-
Ahlström H., Erikson B., Bergström M., et al. Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 195 (1995) 333-337
-
(1995)
Radiology
, vol.195
, pp. 333-337
-
-
Ahlström, H.1
Erikson, B.2
Bergström, M.3
-
57
-
-
0031858913
-
Positron emission tomography with 5-hydroxytriptophan in neuroendocrine tumors
-
Orlefors H., Sundin A., Ahsltröm H., et al. Positron emission tomography with 5-hydroxytriptophan in neuroendocrine tumors. J Clin Oncol 16 (1998) 2534-2541
-
(1998)
J Clin Oncol
, vol.16
, pp. 2534-2541
-
-
Orlefors, H.1
Sundin, A.2
Ahsltröm, H.3
-
58
-
-
0033062098
-
Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography
-
Hoegerle S., Schneider B., Kraft A., et al. Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography. Nuklearmedizin 38 (1999) 127-130
-
(1999)
Nuklearmedizin
, vol.38
, pp. 127-130
-
-
Hoegerle, S.1
Schneider, B.2
Kraft, A.3
-
59
-
-
0034746433
-
F-18 DOPA positron emission tomography for tumor detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
-
Hoegerle S., Altehoefer C., Ghanem N., et al. F-18 DOPA positron emission tomography for tumor detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 28 (2001) 64-71
-
(2001)
Eur J Nucl Med
, vol.28
, pp. 64-71
-
-
Hoegerle, S.1
Altehoefer, C.2
Ghanem, N.3
-
60
-
-
34748868457
-
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl -6-18F-fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma
-
Beuthien-Baumann B., Strumpf A., Zessin J., et al. Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl -6-18F-fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 34 (2007) 1604-1609
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, pp. 1604-1609
-
-
Beuthien-Baumann, B.1
Strumpf, A.2
Zessin, J.3
-
61
-
-
0043194321
-
3-O-methyl -6-18F-fluoro-L-DOPA and its evaluation in brain tumor imaging
-
Beuthien-Baumann B., Bredow J., Burchert W., et al. 3-O-methyl -6-18F-fluoro-L-DOPA and its evaluation in brain tumor imaging. Eur J Nucl Med Mol Imaging 30 (2003) 1004-1008
-
(2003)
Eur J Nucl Med Mol Imaging
, vol.30
, pp. 1004-1008
-
-
Beuthien-Baumann, B.1
Bredow, J.2
Burchert, W.3
-
62
-
-
0029779869
-
Fluorine-18-FDG and iodine-131 uptake in thyroid cancer
-
Feine U., Lietzenmayer R., Scheidhauer K., et al. Fluorine-18-FDG and iodine-131 uptake in thyroid cancer. J Nucl Med 37 (1996) 1468-1472
-
(1996)
J Nucl Med
, vol.37
, pp. 1468-1472
-
-
Feine, U.1
Lietzenmayer, R.2
Scheidhauer, K.3
-
63
-
-
0037329190
-
Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-F-18 fluorodopamine positron emission tomography
-
Gourgiotis L., Sarlis N.J., Reynolds J.C., et al. Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-F-18 fluorodopamine positron emission tomography. J Clin Endocrinol Metab 88 2 (2003) 637-641
-
(2003)
J Clin Endocrinol Metab
, vol.88
, Issue.2
, pp. 637-641
-
-
Gourgiotis, L.1
Sarlis, N.J.2
Reynolds, J.C.3
-
64
-
-
0023026276
-
Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma
-
Oishi S., Sasaki M., Sato T., et al. Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma. Endocrinol Jpn 33 3 (1986) 309-315
-
(1986)
Endocrinol Jpn
, vol.33
, Issue.3
, pp. 309-315
-
-
Oishi, S.1
Sasaki, M.2
Sato, T.3
|